NeuroPace Inc NPCE
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $6.72
- Day Range
- $6.48–6.85
- 52-Week Range
- $5.75–18.15
- Bid/Ask
- $2.65 / $7.42
- Market Cap
- $195.04 Mil
- Volume/Avg
- 47,299 / 92,572
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 2.56
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Total Yield
- —
Company Profile
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all its revenue from the sales of RNS System to hospitals facilities (typically Level 4 CECs) that implant RNS System.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 179
- Website
- https://www.neuropace.com
Comparables
Valuation
|
Metric
|
NPCE
|
PRCT
|
TCMD
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 26.13 |
Price/Book Value | 19.69 | 16.39 | 1.70 |
Price/Sales | 2.56 | 22.70 | 1.21 |
Price/Cash Flow | — | — | 14.42 |
Price/Earnings
NPCE
PRCT
TCMD
Financial Strength
|
Metric
|
NPCE
|
PRCT
|
TCMD
|
|---|---|---|---|
Quick Ratio | 5.31 | 6.37 | 3.77 |
Current Ratio | 6.37 | 7.51 | 4.44 |
Interest Coverage | −2.74 | −26.05 | — |
Quick Ratio
NPCE
PRCT
TCMD
Profitability
|
Metric
|
NPCE
|
PRCT
|
TCMD
|
|---|---|---|---|
Return on Assets (Normalized) | −20.21% | −20.90% | 11.66% |
Return on Equity (Normalized) | −123.13% | −30.98% | 17.56% |
Return on Invested Capital (Normalized) | −16.47% | −25.33% | 13.44% |
Return on Assets
NPCE
PRCT
TCMD
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Lngxbglf | Xvctcj | $195.6 Bil | |||
| Stryker Corp
SYK
| Qrjjsrnh | Ffmf | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Yjhmpvdg | Pprmhk | $122.7 Bil | |||
| Medtronic PLC
MDT
| Ycdjpbbwx | Mymjl | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Yckxhcxvg | Hdrmb | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Vcbx | Xml | $30.7 Bil | |||
| DexCom Inc
DXCM
| Qsbgtxrrv | Dcpnk | $27.0 Bil | |||
| Steris PLC
STE
| Mnfxcnnrv | Jgvlyyy | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Nlmygdbtsf | Lsyb | $22.0 Bil | |||
| Insulet Corp
PODD
| Lfjbrfhwzn | Kkczwv | $16.3 Bil |
United States